ELOX — ELOXX PHARMACEUTICALS INC
As of Q2 2026, 4 SEC-registered investment managers reported holding ELOX (ELOXX PHARMACEUTICALS INC) in their latest 13F filings, with a combined reported value of $32.08K across 2.31K shares. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 4 opened new positions. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
ELOX is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Q2 2026 — 4 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Morgan Stanley history | 1.54K | $21.43K | 0.00% | New |
| UBS Group AG history | 637 | $8.84K | 0.00% | New |
| Wells Fargo & Co history | 126 | $1.75K | 0.00% | New |
| Citigroup Inc history | 4 | $56 | 0.00% | New |
Q3 2023 — 6 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Vanguard Group history | 20.79K | $99.98K | 0.00% | Hold |
| Geode Capital Management history | 19.59K | $93.26K | 0.00% | Reduce |
| Wells Fargo & Co history | 1.17K | $5.64K | 0.00% | Hold |
| UBS Group AG history | 291 | $1.40K | 0.00% | New |
| Morgan Stanley history | 79 | $380 | 0.00% | Hold |
| JPMorgan Chase & Co history | 1 | $5 | 0.00% | Hold |
Q2 2023 — 5 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Vanguard Group history | 20.69K | $80.47K | 0.00% | Hold |
| Geode Capital Management history | 20.26K | $78.81K | 0.00% | Hold |
| Wells Fargo & Co history | 1.17K | $4.54K | 0.00% | Hold |
| Morgan Stanley history | 79 | $307 | 0.00% | Hold |
| JPMorgan Chase & Co history | 1 | $4 | 0.00% | Hold |
Q1 2023 — 7 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Vanguard Group history | 20.69K | $51.92K | 0.00% | Reduce |
| Geode Capital Management history | 20.24K | $50.80K | 0.00% | Hold |
| Wells Fargo & Co history | 1.17K | $2.93K | 0.00% | Hold |
| UBS Group AG history | 469 | $1.18K | 0.00% | Add |
| Bank of America Corp history | 371 | $931 | 0.00% | Reduce |
| Morgan Stanley history | 79 | $198 | 0.00% | Reduce |
| JPMorgan Chase & Co history | 1 | $0 | — | Hold |
Q4 2022 — 7 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Vanguard Group history | 40.41K | $73.55K | 0.00% | Reduce |
| Bank of America Corp history | 1.95K | $3.55K | 0.00% | Reduce |
| Wells Fargo & Co history | 1.17K | $2.12K | 0.00% | Reduce |
| UBS Group AG history | 123 | $224 | 0.00% | New |
| Morgan Stanley history | 80 | $146 | 0.00% | Reduce |
| Geode Capital Management history | 20.20K | $36 | 0.00% | Reduce |
| JPMorgan Chase & Co history | 1 | $0 | — | Reduce |
Q3 2022 — 10 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Vanguard Group history | 2.70M | $459.00K | 0.00% | Reduce |
| Geode Capital Management history | 807.68K | $137.00K | 0.00% | Add |
| BNY Mellon history | 145.38K | $25.00K | 0.00% | Hold |
| Renaissance Technologies history | 133.50K | $23.00K | 0.00% | Reduce |
| Northern Trust Corp history | 123.67K | $21.00K | 0.00% | Hold |
| Citadel Advisors history | 58.62K | $10.00K | 0.00% | Reduce |
| Bank of America Corp history | 58.02K | $10.00K | 0.00% | Hold |
| Wells Fargo & Co history | 46.70K | $8.00K | 0.00% | Hold |
| Morgan Stanley history | 3.18K | $1.00K | 0.00% | Hold |
| JPMorgan Chase & Co history | 87 | $0 | — | Add |
New Positions (Q2 2026)
- Morgan Stanley 1.54K sh · $21.43K
- UBS Group AG 637 sh · $8.84K
- Wells Fargo & Co 126 sh · $1.75K
- Citigroup Inc 4 sh · $56
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 18 funds)
| Fund | Q2 2026 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley | 1.54K | 79 | 79 | 79 | 80 | 3.18K | 3.18K | 5.63K | 3.69K | 793 |
| UBS Group AG | 637 | 291 | — | 469 | 123 | — | — | 21.85K | — | — |
| Wells Fargo & Co | 126 | 1.17K | 1.17K | 1.17K | 1.17K | 46.70K | 46.71K | 46.67K | 46.67K | 21.37K |
| Citigroup Inc | 4 | — | — | — | — | — | — | — | — | — |
| Citadel Advisors | — | — | — | — | — | 58.62K | 111.76K | — | 68.05K | 228.09K |
| Fidelity Management & Research (FMR) | — | — | — | — | — | — | — | — | — | 338 |
| JPMorgan Chase & Co | — | 1 | 1 | 1 | 1 | 87 | 41 | 622 | 41 | 41 |
| Goldman Sachs Group | — | — | — | — | — | — | — | — | — | 27.59K |
| Renaissance Technologies | — | — | — | — | — | 133.50K | 179.40K | — | — | — |
| Two Sigma Investments | — | — | — | — | — | — | — | 23.08K | 117.73K | 314.87K |
| Bank of America Corp | — | — | — | 371 | 1.95K | 58.02K | 58.09K | 58.21K | 17.22K | 6.08K |
| BNY Mellon | — | — | — | — | — | 145.38K | 145.38K | 146.29K | 146.29K | 76.12K |
| D. E. Shaw & Co | — | — | — | — | — | — | 21.30K | 21.30K | 21.30K | 63.70K |
| Geode Capital Management | — | 19.59K | 20.26K | 20.24K | 20.20K | 807.68K | 802.41K | 800.33K | 798.06K | 772.84K |
| Millennium Management | — | — | — | — | — | — | — | 105.88K | 175.56K | 274.30K |
| Northern Trust Corp | — | — | — | — | — | 123.67K | 123.67K | 123.67K | 124.37K | 124.37K |
| T. Rowe Price Associates | — | — | — | — | — | — | — | — | — | 22.70K |
| Vanguard Group | — | 20.79K | 20.69K | 20.69K | 40.41K | 2.70M | 2.82M | 2.82M | 3.04M | 3.05M |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details